Dapivirine News and Research

RSS
Dapivirine is an experimental non-nucleoside reverse transcriptase inhibitor. A gel formulation of dapivirine is now being investigated as a vaginal microbicide.
Study: Adolescent girls and young women can and will use HIV prevention products with consistency

Study: Adolescent girls and young women can and will use HIV prevention products with consistency

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

Researchers report trial results of rectal microbicides at HIV R4P Virtual Conference

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

WHO recommends dapivirine vaginal ring as additional HIV prevention choice for at-risk women

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

Researchers launch study to evaluate safety of HIV prevention methods in breastfeeding women

Monthly vaginal ring for HIV prevention receives positive opinion from EMA

Monthly vaginal ring for HIV prevention receives positive opinion from EMA

Monthly vaginal ring moves one step closer to becoming a new HIV prevention method

Monthly vaginal ring moves one step closer to becoming a new HIV prevention method

Study to evaluate safety of PrEP and dapivirine ring in pregnant women

Study to evaluate safety of PrEP and dapivirine ring in pregnant women

New clinical trial to examine the safety of dapivirine vaginal ring and PrEP in pregnant women

New clinical trial to examine the safety of dapivirine vaginal ring and PrEP in pregnant women

Vaginal ring used by most women for HIV prevention in open-label study

Vaginal ring used by most women for HIV prevention in open-label study

New clinical trial aims to examine safety and use of two HIV prevention tools

New clinical trial aims to examine safety and use of two HIV prevention tools

MTN launches new study to empower teen girls with choices in HIV prevention

MTN launches new study to empower teen girls with choices in HIV prevention

IPM begins first clinical trial of vaginal rings to prevent HIV in women

IPM begins first clinical trial of vaginal rings to prevent HIV in women

NIH-supported first HIV vaccine efficacy study begins in South Africa

NIH-supported first HIV vaccine efficacy study begins in South Africa

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

Women report experimental vaginal ring for HIV prevention did not negatively affect sexual experience

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

HOPE study seeks to understand safety of vaginal ring in protecting women against HIV

Dapivirine ring can help prevent HIV-1 infection in women

Dapivirine ring can help prevent HIV-1 infection in women

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

Researchers complete participants’ enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

ASPIRE completes patient enrollment in Phase III trial of vaginal ring for HIV prevention

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland